D.P. has received research support from AbbVie, Eli Lilly, MSD, Novartis, Pfizer, consulting fees from AbbVie, Bristol-Myers Squibb, Eli Lilly, Janssen, Moonlake, Novartis, Pfizer and UCB, and speaker fees from AbbVie, Canon, DKSH, Eli Lilly, Janssen, MSD, Medscape, Novartis, Peervoice, Pfizer and UCB, and is a member of the Assessment of SpondyloArthritis International Society executive committee and of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis steering committee.